Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2024 STOCKHOLM, July 16, 2024 /PRNewswire/ — Second Quarter 2024 Total revenue increased 12 per cent, 11 per cent at constant exchange rates, (CER), to SEK 5,442 M (4,872) Haematology revenue…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.